Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. ENLIE Pharmaceutical JSC's retained earnings for the quarter that ended in Dec. 2019 was ₫-2,595 Mil.
ENLIE Pharmaceutical JSC's quarterly retained earnings
declined
from Dec. 2018 (₫0 Mil) to Jun. 2019 (₫-2,183 Mil) and
declined
from Jun. 2019 (₫-2,183 Mil) to Dec. 2019 (₫-2,595 Mil).
ENLIE Pharmaceutical JSC's annual retained earnings
declined
from Dec. 2021 (₫-18,397 Mil) to Dec. 2022 (₫-19,861 Mil) and
declined
from Dec. 2022 (₫-19,861 Mil) to Dec. 2023 (₫-25,544 Mil).
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
ENLIE Pharmaceutical JSC Retained Earnings Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
What does a Retained Earnings of ₫-2,595 Mil mean?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Retained Earnings of ₫-2,595 Mil as of Dec. 2019. Retained earnings is the amount of net income not issued to shareholders. View historical data on ENLIE Pharmaceutical JSC and its competitors.
Is ENLIE Pharmaceutical JSC's Retained Earnings too high?
ENLIE Pharmaceutical JSC's current Retained Earnings is ₫-2,595 Mil. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Retained Earnings compare to ?
ENLIE Pharmaceutical JSC's Retained Earnings of ₫-2,595 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on ENLIE Pharmaceutical JSC and its competitors. ENLIE Pharmaceutical JSC's current Retained Earnings is ₫-2,595 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Retained Earnings of ₫-2,595 Mil. The current Retained Earnings is ₫-2,595 Mil. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Retained Earnings is ₫-2,595 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ENLIE Pharmaceutical JSC is a Vietnamese pharmaceutical company engaged in the manufacture and trade of pharmaceutical products, medical supplies, cosmetics, foods, and functional foods. Its operations span production and wholesale distribution, serving pharmacies, hospitals, clinics, and other healthcare providers across Vietnam, with additional activity in the wholesale of installation materials and construction equipment. The company's revenue derives primarily from the sale of its own manufactured pharmaceutical and healthcare products, supplemented by trading and distribution of third-party goods and non-pharmaceutical wholesale operations. Its product portfolio covers both conventional medicines and health-related consumer goods, positioning it within Vietnam's domestic healthcare and consumer products market.
25GF Score
Get the complete analysis for HSTC:BCP
Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:BCP has been successfully added to your 
